73% of Medicare Advantage enrollees in California, about 2,251,200 people, could be turned down for a Medigap policy, KFF estimates
By MyMedicarePlans Data Desk · Published · Last updated · Data: KFF analysis of 2023 Medicare Advantage data (October 2026)
On this page: The finding Chart Table Cite Methodology More for California Contact
73% of Medicare Advantage enrollees in California, about 2,251,200 people, had a health condition in 2023 that could get them turned down for a Medigap supplemental policy, according to a KFF analysis published in October 2026.
Nationally KFF's estimate is 74%, about 20.9 million people.
California's rule on buying Medigap outside a guaranteed issue right, as KFF's review of state rules records it: Outside a guaranteed issue right, insurers can ask health questions and decline.
The estimate is of who could be declined. No insurer publishes how many applicants it approves or declines.
The chart
The table behind it
| Place | Share who could be turned down (KFF) | People (KFF) |
|---|---|---|
| California | 73% | 2,251,200 |
| United States | 74% | 20,900,000 |
The same rows as a CSV file at a stable address, with a header row.
Cite this
Credit line: Source: KFF analysis of 2023 Medicare Advantage data (October 2026); state rules, KFF; compiled with CMS plan counts by MyMedicarePlans.org (https://mymedicareplans.org/newsroom/medigap/underwriting/)
Reference: MyMedicarePlans.org Data Desk (2026). KFF: 73% of Medicare Advantage Enrollees in California, About 2,251,200, Could Be Turned Down for Medigap. MyMedicarePlans.org. https://mymedicareplans.org/newsroom/findings/medicare-advantage-enrollees-who-could-be-denied-medigap-kff/california/
Data: KFF. Republish with credit to KFF and MyMedicarePlans.org. The estimate is KFF's, not ours: credit KFF first, and link KFF's analysis. Terms and how to cite.
Methodology
- Source
- KFF, Nearly Three-Quarters of Medicare Advantage Enrollees Could be Denied a Medigap Policy Due to a Pre-Existing Condition (published 2026-10-13), figures from KFF's published chart data. The underwriting desk's method.
- Date retrieved
- KFF's chart data retrieved 2026-11-03.
- Sample
- Medicare Advantage enrollees in California in 2023, as analyzed by KFF.
- How it was calculated
- KFF's published figures, unchanged. Nothing here is recalculated.
- Known limits
- KFF's estimate, from 2023 data: who had a condition on the applications of the six largest Medigap insurers.
- It measures who could be turned down, not who was: no insurer publishes approval or decline rates.
- State rules can protect people regardless of health; the estimate does not adjust for them.
- The state figures are KFF's and are rounded as KFF published them.
The full data: California on the underwriting desk. Every dataset: the data library.
More numbers for California
- The national finding: 74% of Medicare Advantage enrollees, about 20.9 million people, could be turned down for a Medigap policy, KFF estimates
- 74 of the 402 Medicare Advantage plans offered in California are not returning in 2027
- 394 Medicare Advantage plans are offered in California for 2027, against 402 in 2026
- 4 organizations that offered Medicare Advantage plans in California in 2026 offer none there for 2027; 1 is new
- 44 of 56 counties in California lose at least one Medicare Advantage plan in 2027
- 26 of 56 counties in California have fewer Medicare Advantage plans in 2027 than in 2026; 22 have more
- 3 of 58 counties in California have no Medicare Advantage plan open to general enrollment in 2027
- 67.1% of general-enrollment Medicare Advantage plans with drug coverage in California, 169 of 252, charge a $0 monthly premium in 2027
- 59 of 209 general-enrollment Medicare Advantage plans with drug coverage in California raise their monthly premium for 2027; 11 lower it and 139 keep it the same
- Kaiser Permanente enrolls 41.0% of Medicare Advantage members in California, as of May 2026
- One insurer enrolls a majority of Medicare Advantage members in 19 of 56 counties in California
- 181 of 359 rated Medicare Advantage plans in California (50.4%) have 4 stars or more in CMS's 2027 Star Ratings
- 0 of 359 rated Medicare Advantage plans in California have 5 stars in CMS's 2027 Star Ratings
- 72.7% of Medicare Advantage enrollees in California are in contracts CMS rates 4 stars or higher for 2027
- 77 chronic condition Special Needs Plans (C-SNPs) are offered in California for 2027, up from 68 in 2026
- 50 dual-eligible Special Needs Plans (D-SNPs) are offered in California for 2027, down from 54 in 2026
- 10 stand-alone Medicare Part D drug plans are offered in California for 2027, down from 12 in 2026
- 0 stand-alone Part D plans with a $0 monthly premium are offered in California for 2027, down from 1 in 2026
- The lowest stand-alone Medicare Part D premium in California in 2027 is $5.30 a month, against $0.00 in 2026
- 0 stand-alone Part D plans with a $0 deductible are offered in California for 2027, down from 2 in 2026
- 1 stand-alone Part D plans that cost $0 a month with full Extra Help are offered in California for 2027, down from 2 in 2026
- At least 15 insurers sell Medigap policies in California, on Medicare.gov's search for one ZIP code
- 9,726 people and companies with an address in California are on the HHS inspector general's exclusion list
- Medicare Advantage Share Index: California
- California: the newsroom's brief, with every county
Questions about the data
Write to [email protected]: a custom cut of the data (a county list, a region, a chart in your outlet's size) is usually a same-day reply.
For a quote or an interview, write to the same address and the desk that covers it answers: the Data Desk for the plan counts and the county data, the Costs & Policy Desk for Part D, premiums, IRMAA and Extra Help, the Editorial Desk for how Medicare works, Medigap and enrollment. Every answer comes from the CMS files and Medicare's own rules.
MyMedicarePlans.org is a Medicare guide: plain-language answers and plan data for people choosing coverage. The counts here come only from the CMS files, and the method is above. Not connected with or endorsed by the U.S. government or the federal Medicare program.